Perceptions of Biosimilars Among Healthcare Providers in Saudi Arabia
Biosimilars are safe and effective treatments for chronic diseases such as cancer and rheumatoid arthritis. The Saudi Food and Drug Authority (SFDA) manages the quality and registration of biosimilars in the Kingdom of Saudi Arabia. However, disparities among regulatory authorities, such as the abse...
Saved in:
Main Authors: | Mohammed Alqahtani, Ahmed Al-jedai, Albert Wertheimer |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Minnesota Libraries Publishing
2024-11-01
|
Series: | INNOVATIONS in Pharmacy |
Subjects: | |
Online Access: | https://pubs.lib.umn.edu/index.php/innovations/article/view/6371 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of infliximab biosimilar on retinal microvasculature in Crohn’s disease patients evaluated by optical coherence tomography angiography
by: Hesham M. El Mazar, et al.
Published: (2025-01-01) -
Biologics in ocular inflammatory diseases – Experience from a tertiary referral eye care center in South India
by: Kalpana Babu, et al.
Published: (2025-02-01) -
Insights into simulation-based learning: student and faculty experiences in a PharmD program in Saudi Arabia
by: Reem Binsuwaidan, et al.
Published: (2025-02-01) -
Patient satisfaction with dental services provided by Taif University Dental Hospital, Saudi Arabia
by: Mohammed A. Alzubaidi, et al.
Published: (2024-12-01) -
The Effect of Risk Perception and Online Trust on Purchase Intention in E-Commerce
by: Muhamammad Ikhlash, et al.
Published: (2024-10-01)